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Abstract
αβ T cell differentiation from thymic precursors is a complex process, explored here with the
breadth of ImmGen expression datasets, analyzing how differentiation of thymic precursors gives
rise to transcriptomes. After surprisingly gradual changes though early T commitment, transit
through the CD4+CD8+ stage involves a shutdown or rare breadth, and correlating tightly with
MYC. MHC-driven selection promotes a large-scale transcriptional reactivation. We identify
distinct signatures that mark cells destined for positive selection versus apoptotic deletion.
Differential expression of surprisingly few genes accompany CD4 or CD8 commitment, a
similarity that carries through to peripheral T cells and their activation, revealed by mass
cytometry phosphoproteomics. The novel transcripts identified as candidate mediators of key
transitions help define the “known unknown” of thymocyte differentiation.
Introduction
The Immunological Genome Project (ImmGen) is an international collaboration of
laboratories that collectively perform a thorough dissection of gene expression and its
regulation in the immune system of the mouse. Here, we track the transcriptome through the
entire differentiation pathway of T cells in the thymus against the backdrop of all ImmGen
data, finding unexpectedly gradual changes, sharp breakpoints, and similarities.
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tThe vertebrate thymus is where hematopoietic precursors differentiate into T cells. This
differentiation process has been intensively studied over several decades 1, resulting in what
is arguably the most finely parsed of any differentiation cascade among mammalian cell-
types 2-9. The sequence runs from the commitment of lymphoid precursors to the T cell
lineage, random rearrangement of T cell receptor (TCR) genes, and selection that allows
maturation of only those thymocytes bearing potentially useful TCR specificities (positive
selection) and that do not overreact to self (negative selection). These steps are distinguished
by the expression of certain cell surface molecules. The most immature thymocytes lack the
expression of the CD4 and CD8 co-receptors (double negative, DN) and can be further
subdivided into subsets that track the commitment to become T cells using CD25 and CD44
expression 10, along with c-KIT (reviewed by 11) and CD28 12. Functional rearrangement
and expression of a γδ TCR promotes proliferation accompanied by early maturation of DN
progenitors and subsequent emigration from the thymus 13.
In contrast, successful TCRβ  gene rearrangement in the DN subset initiates several rounds of
proliferation essential for αβ  differentiation and the generation of CD4+CD8+ double
positive (DP) thymocytes 14, where TCRα  rearrangement takes place. DP thymocytes screen
thymic cortical epithelial cells for the potential of their TCR to interact with peptide-MHC
complexes (pMHC) 15-18. Those DP thymocytes bearing TCR that cannot bind self-pMHC
(thought to be the majority) die within three to four days 19. Those DP thymocytes that
express a TCR that can interact with MHC class I or MHC class II molecules are positively
selected and correspondingly mature as CD4−CD8+ single positive (CD8SP) or CD4+CD8−
(CD4SP) thymocytes (lineage commitment) 20. This positive selection process differs from
β -selection, as it occurs in absence of extensive proliferation. If the affinity of the TCR-
pMHC interaction is too high, thymocytes are eliminated by apoptosis (clonal deletion), or
diverted into alternative lineages such as CD8αα  T cells or FOXP3+ regulatory T (Treg)
cells 21, 22. Thymocytes that survive these processes are exported from the thymus and
undergo a phase of post-thymic maturation to become functional CD4+ and CD8+ T cells
(23).
Several of the molecular mediators required for progression through certain stages of
thymocyte differentiation have been defined by genetic approaches. What is lacking is a
general perspective of how these and other pathways integrate to direct thymocyte
differentiation in an unperturbed system. Although numerous studies have profiled
thymocyte transcriptomes 24-33, these focused on only limited transitions or selected
checkpoints.
Here, we revisited the entire spectrum of differentiation states in the αβ  T cell branch of the
lymphoid tree from a transcriptional standpoint, using the breadth of ImmGen datasets. This
analysis revealed unexpected aspects of T cell differentiation and identified candidate genes
whose coordinate regulation at certain transitions hinted at important functions during
thymocyte selection and maturation.
Results
Overall perspective of T cell differentiation
We generated gene expression profiles from every stage of thymocyte maturation from early
thymic progenitors (ETP) to the most mature single positive (SP) thymocytes ready for
export from the thymus (see Supplementary Table 1 for the complete list of population
names, abbreviations, and markers used for cell sorting). Profiles from bone marrow
progenitors and peripheral naïve T cells were also included. All datasets were generated in
duplicate or triplicate from cells obtained from 6 week-old C57Bl/6 male mice. To validate
these data, we first assessed the behavior of over 50 well-characterized genes that mark key
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tevents in thymocyte differentiation, such as Rag1, Tcra, or Tcrg; the expected expression
patterns were observed (Fig. 1a, Supplementary Fig. 1 and data not shown). We used several
mathematical tools for multivariate analysis to determine the relationships between
populations. Unsupervised hierarchical clustering reproduced the known differentiation
sequence with striking accuracy (Fig. 1b), indicating that there were no hidden surprises in
the αβ  T cell branch of the hematopoietic tree determined over the past three decades, and
that transcriptional relationships do evolve linearly along differentiation.
We then used Principal Component Analysis (PCA) to map cell populations in a 3D space
(Fig. 1c), which again matched the differentiation sequence, but also grouped stages into
distinct pods, such as the tightly-knit group of mature SP cells. PCA of the entire ImmGen
dataset brought forth a dominant component (PC1, 73% of variance) which tracked
generically with maturation in immune lineages (Fig. 1c and data not shown), reminiscent of
the major “differentiation” component observed in multivariate mass cytometry analysis of
bone marrow cells 34. γδ T cell maturation proceeded directly from the DN3 precursors,
while αβ  T cells first ‘regressed’ along this principal component through the intermediate
single positive (ISP) and DP stages. For subsequent analyses, we excluded γδ T cells
(discussed elsewhere 35) and the DN4 subset (which incorporates both αβ TCR and γδ TCR
thymocytes).
The magnitude of transcriptional changes throughout differentiation was better visualized by
plotting the cumulative Euclidean distance between populations (Fig. 1d) or the number of
transcripts induced or repressed at each transition (Fig. 1e). These two metrics identified
three main “tectonic shifts”: between bone marrow precursors and early thymic progenitors
(ETPs); at the transition through DN3a; and (the strongest one) around the DP compartment.
Contrary to what had been shown for cells developing in OP9-DL1 cocultures 31, in vivo
commitment to the T cell lineage at the DN2a to DN2b transition was associated with
relatively moderate changes (Fig. 1d-e). Although DP blasts resembled earlier β -selected
populations, small DP cells were drastically different. Small DP thymocytes were also very
different from CD69+ DP, indicating that TCR signaling in DP thymocytes initiated yet
another major transcriptional change. In contrast, the transition from CD69+ to terminal
CD4SP or CD8SP involved comparatively minor changes, and CD4+ and CD8+ cells looked
extremely similar from this perspective (Fig. 1d-e). Finally, egress from the thymus to the
periphery had a very small transcriptional impact. Thus, relationships among the
transcriptomes recapitulated the currently accepted developmental progression of thymocyte
differentiation, and provided several new insights into the transcriptional basis of key
transitions.
Early T cell differentiation
The major landmarks of early T cell differentiation (i.e. loss of B cell potential within the
ETP and irreversible commitment to the T cell lineage at the DN2a to DN2b transition)
happen in a rather discrete manner 9. By contrast, the transcriptional changes in most genes,
including many key regulators, were gradual. For example, the expression of the T lineage
commitment factor Bcl11b 32, 36, 37 not only increased from DN2a to DN2b when
commitment actually occurs, but also before (ETP to DN2a) and after (DN2b to DN3a)
(Supplementary Fig. 1). The gradual nature of gene expression changes was a common
feature throughout early T cell differentiation (see below) and may indicate that these
transitions are not ‘radical’ events but rather proceed by degrees or, more prosaically, that
they are not synchronized with changes in the few cell surface markers used to identify
differentiation intermediates.
To group those transcripts with similar behavior during early thymocyte differentiation, we
applied k-means clustering to a set of 2088 most variable genes. The resulting clusters (Fig.
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t2a-b, Supplementary Table 2; clusters named by a characteristic gene or group of genes)
included genes with previously assigned functions in thymocyte differentiation (e.g. about
half of the probes for “Tcf-1 and Lef-1” and “Cd4 and Cd8” clusters), but also numerous
genes whose function was not previously studied in T cells, providing a rich resource for
discovering novel molecular players in thymocyte differentiation.
An important feature of early T-cell differentiation is the shutdown of progenitor and non-T
lineage programs 38. The “c-Kit”, “Cd34” and “PU.1” clusters (Fig. 2a-b, Supplementary
Table 2) contained genes that were gradually downregulated from haematopoietic stem cells
to DN3, including haematopoietic progenitor cell markers such as Flt3, Cd34, Ly6a (Sca-1)
and Kit, as well as a small group of genes typical of non-T cell lineages (B, NK or myeloid).
Transcriptional regulators that fell into these clusters included Bcl11a, Hhex, Jun, Meis1,
Mef2c, and Sfpi1 (PU.1) (Fig. 2c).
Commitment to the T cell lineage is associated with the rearrangement of Tcrb, Tcrg and
Tcrd loci and induction of TCR signaling machinery. The “Gata-3” and “Tcf-1 and Lef-1”
clusters that were upregulated in early thymocytes and plateaued around the DN3a stage of
T cell differentiation (Fig. 2a-b) included recombination genes (Rag1 and Lig4) and a major
subset of genes related to TCR signaling (Cd3d, Cd3e, Cd3g, Lck, Itk, Grap2 (GADS),
Rasgrp1, Zap70, Cbl, and Nck2) (Supplementary Fig. 2). Several intriguing genes encoding
proteins with likely signaling functions also fell into these clusters (Fig. 2b). For example,
Arpp21 encodes RCS, a competitive inhibitor of calmodulin-dependent enzymes, including
calcineurin 39 and is thus a putative negative regulator of TCR signaling 40. Diacylglycerol
(DAG) kinase epsilon (Dgke) that converts DAG to phosphatidic acid may also regulate
TCR signaling at this stage, as was suggested for DAG kinases alpha and zeta 41, 42. More
generally, there were interesting shifts in the entire DGK family during thymocyte
differentiation (Fig. 2d).
NOTCH signaling is necessary for commitment to the T cell lineage and is indispensable at
all steps of T cell differentiation prior to the DP stage 8, 9. Direct NOTCH targets were
distributed across multiple clusters with very different patterns of expression. Many
canonical NOTCH targets, such as Ptcra (preTCRα ) 43, 44, Dtx1, Il7r 45 and Notch1 itself 46
fell into “preTCRα ” and “Il7r” clusters that peak around DN3a stage (Fig 2a), consistent
with the notion that DN3a cells receive the highest level of NOTCH signaling 46, 47. A few
targets, like Nrarp and Hes1 (in corresponding clusters), were upregulated and plateaued as
early as in ETP thymocytes (Fig 2a). Two NOTCH targets of particular interest were the
transcription factors Tcf7 48, 49 and Bcl11b 32, 36, 37 (both in “Tcf-1 and Lef-1” cluster).
These genes were upregulated early on, plateaued by the DN3a stage, then were maintained
at a high level of expression, even upon downmodulation of NOTCH signaling following β -
selection. Thus, NOTCH signaling is required for induction, but not maintenance, of these
key regulators of T cell differentiation, consistent with the finding that NOTCH is required
early in T cell differentiation but is dispensable for maintenance of T cell identity. Finally,
Myc 50 (from the “c-Myc” cluster) exhibited yet another pattern with steady expression
early on and an abrupt drop in DP thymocytes. It is therefore very likely that additional
factors other than NOTCH regulate expression of NOTCH targets resulting in the observed
diversity of expression patterns in early thymocyte differentiation.
β-selection-induced T cell program
Expression of a productively rearranged Tcrb locus complexed with the germline-encoded
preTCRα  chain (preTCR) by DN3 thymocytes allows ‘β -selection’, a process that drives a
burst of proliferation and phenotypic progression to the DN4 (with the downregulation of
CD25), ISP (with the upregulation of CD8), and DP stages (with the upregulation of both
CD4 and CD8 co-receptors) 51. The upregulation of CD28 is one of the earliest marks of β -
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tselection, occurring prior to the complete downregulation of CD25, thus distinguishing post
β -selected DN3b cells from non-selected DN3a cells 12. The transition from the DN3a to
DN3b stage was associated with one of the most prominent shifts in the thymocyte
transcriptome (Fig. 1c-e). Much of this change was related to proliferation (>48%) (Fig. 3a)
or metabolism (data not shown). Known components of the β -selection program were also
included in the “TCRα ” and “Cd4 and Cd8” clusters (e.g. Cd4, Cd8a, Cd8b1, Rorc), along
with several regulators not previously recognized in the context of thymocyte differentiation
(Chd1, Klf7, Mef2a, Meir1, Pou6f1, and Suhw4 (Zfp280d) (Fig. 2b-c).
Do all TCR-mediated signals proceed similarly? We analyzed the overlap between genes
induced by signaling from the preTCR (DN3a to DN3b transition) or the αβ TCR in
immature DP thymocytes (small DP to CD69+ DP transition) or in peripheral T cells (CD8 T
cells from unchallenged versus Listeria-OVA challenged OTI mice) to determine whether a
common transcriptional program was engaged downstream of these receptors at various
stages of T cell differentiation. Proliferation signature genes were strongly induced by both
the preTCR at the DN3 stage and the αβ TCR in peripheral T cells, but not in DP
thymocytes, and were therefore excluded from this analysis (Fig. 3b). Unexpectedly,
transcriptional programs induced by β -selection and peripheral T cell activation were largely
overlapping, with very few genes selectively induced by the preTCR, among which were
Rorc, Zap70, Cd8, Etv5 and Ikzf3, for example. In contrast, TCR signaling at the DP stage
appeared to be very distinct from the β -selection transcriptional program. Several markers of
TCR signal strength (Cd69, Cd5, Nr4a1) were induced downstream of both the preTCR and
the αβ TCR in DN and DP thymocytes, respectively, but the magnitude of their induction
was lower during β -selection (Fig. 3b).
PreTCR signals are known to antagonize NOTCH signaling 46, 47. Accordingly, a wide array
of NOTCH pathway components were downregulated upon β -selection (Fig. 3a): the Notch1
and Notch3 receptors themselves; Lfng, a glycosyltransferase that enhances sensitivity of
NOTCH receptors to Delta-like ligands; Maml2, a NOTCH transcriptional coactivator;
Dtx1, Dtx3 and Dtx3l, which are members of Deltex family of NOTCH regulators; and
NOTCH targets, Hes1, Il2ra, Ptcra (preTCRα ) 44. Other NOTCH targets, like Il7r 45, 50 and
Myc14, 50, 52, were also downregulated at the transcriptional level, but with delayed kinetics
(Fig. 3c). The delayed downregulation of Myc was also observed at the protein level (Fig.
3d). MYC protein amounts actually increased 3-fold following β -selection, in accordance
with its mitogenic role at the β -selection checkpoint 14, 50, 52, 53, then was virtually
undetectable by the DP stage. This drop in protein level was first observed at the ISP stage
without a strong decrease at the mRNA level (Fig. 3d), a divergence which coincided with
the upregulation of several of MYC post-transcriptional and functional regulators: Trpc4ap,
which targets MYC for ubiquitination 54; Mxi1 and Sin3b, which antagonize transactivation
functions of c-MYC/MAX dimers 55, 56 (Fig. 3d). Altogether, these observations hinted at
post-transcriptional mechanisms that regulate MYC expression.
In addition to MYC activity 53, the burst of proliferation triggered by β -selection requires
both preTCR and NOTCH signaling 57, 58 and is augmented by IL-7R signals. Yet, preTCR
expression shut down NOTCH signaling and therefore negatively regulated these mitogenic
pathways. Thus, this delayed shutdown may serve as a molecular timer that sets in motion
the transcriptional changes ultimately associated with transition to the quiescent small DP
stage (Fig. 3e). Accordingly, when Myc expression shutdown was prevented by ectopic
expression of Myc at the DP stage, DP thymocytes failed to acquire the small cell size
characteristic of the resting small DP stage (Supplementary Fig. 3a). The positive correlation
between Myc expression and the size of DP cells (Supplementary Fig. 3b) indicated that
Myc downregulation may be one of the key molecular events driving the transition towards
the quiescent small DP phenotype. Consistent with these results, both deletion of Myc and
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ttransgenic expression of the MYC-inhibitor MAD1 at the DN3 stage led to a marked
decrease in thymocyte cell size 53, 59.
Small DP cells
Transition from the DP blast to the small DP stage was associated with the most drastic
change to the thymocyte transcriptome. An unusual feature of this shift was that many more
genes appeared downregulated (1448 probes with FoldChange (FC) <0.5) than upregulated
(225 probes with FC>2) (Fig. 1e). Much of this transcriptional shutdown affected genes
involved in proliferation and various housekeeping activities such as translation, RNA
processing and numerous metabolic processes (Supplementary Fig. 4 and data not shown).
This observation was exemplified by the downregulation of the ribosomal protein S6 (a part
of 40S ribosomal subunit) at the transcriptional and protein level (Supplementary Fig. 5).
The broad shutdown of metabolism-related genes in small DP was not merely a result of
cell-cycle exit. When the expression of genes from the metabolism and proliferation-related
gene ontology (GO) categories were simultaneously analyzed across the entire ImmGen
dataset, many populations exhibited the expected ‘low proliferation’ phenotype (Fig. 4a,
bottom), but very few the ‘low metabolism’ signature (Fig. 4a, top). Cell types that
shutdown their metabolism-related transcriptome to a similar extent to small DP included T
cells at the contraction phase of the immune response, neutrophils, microglia and red pulp
macrophages (Fig. 4a-b). Neutrophils, like small DP thymocytes, have a lifespan of several
days and have reduced transcription and translation activities and few mitochondria 60.
Fraction D pre-B cells also undergo a similar shutdown of metabolism and proliferation-
related genes (although to a lesser extent) (Fig. 4a) and, like small DP cells, are on the cusp
of an antigen receptor-controlled checkpoint. Given that huge numbers of cells within these
subsets are destined to die due to the failure to express a ‘useful’ antigen receptor,
acquisition of this ‘low metabolism state’ may be an adaptation that reduces the energy cost
of the inevitable waste in generating an adaptive immune system.
MYC was recently described as a global amplifier of transcription driven by RNA
polymerases I and III 61. Therefore, the strong downregulation of Myc expression and
parallel upregulation of MYC negative regulators at the small DP stage (Fig. 3d) suggested
that the extent of the transcriptional shutdown may be even greater than surmised after
normalization of microarray data, which only assesses relative amounts of transcripts in a
cell, but can miss widespread variation 62. To test this hypothesis, we quantified total RNA
levels by cytometric analysis of pyronin Y staining (Fig. 4c). RNA content was decreased in
small DP cells compared to neighboring subsets (DN, DP blast, CD4SP and CD8SP), in
accord with a previous report that detected ten times less total RNA in small DP thymocytes
relative to DN4 cells 63. We also assessed actual transcription via 5-Ethynyl Uridine (eU)
incorporation. An abrupt decrease in de novo RNA synthesis occurred at the small DP stage
and was thus a major contributor to the transcriptional shutdown observed in small DP cells.
Altogether, these data indicated that RNA transcription was globally suppressed at the small
DP stage, and that genes associated with metabolic and housekeeping activities were
disproportionally affected during this shutdown.
CD69+ DP, crossroad of multiple fates
Small DP cells audition for positive selection by scanning for self-peptide-MHC interactions
with their newly rearranged αβ TCR 64. DP thymocytes that receive a TCR signal following
pMHC engagement upregulate CD69 65. The small DP to CD69+ DP transition was
associated with the second most dramatic change in transcriptome throughout thymocyte
differentiation. Accordingly, side-by-side comparison of the CD69+ DP and small DP gene
expression profiles revealed a large number of differentially expressed genes (Fig. 5a). As
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texpected, a major part of the program induced in CD69+ DP thymocytes was composed of
early, generic TCR activation genes, as shown by the clear partition of the signature genes
characterizing TCR-stimulated DP thymocytes (Fig. 5a). Most of these TCR-related genes
(75% of the upregulated signature genes) were not DP-specific as they were shared with
other instances of TCR signaling, in particular in peripheral T cells (data not shown), and
thus belonged to generic branches of TCR-controlled gene networks. Accordingly, a large
number of immediate early response genes and canonical TCR transcriptional regulators
(including NFAT, NF-κ b, EGR, FOS, REL, NUR77 family members) were present among
the upregulated signature genes (Fig. 5a).
Analysis of transcriptional regulators that were not part of this signature (Fig. 5b) revealed
genes with possible functions in thymic positive selection. For instance, the genes encoding
the inhibitory molecules ID2 and ID3, proposed to relieve the differentiation blockade
enforced at the DP stage by E-proteins 66-68, were markedly upregulated in CD69+ DP
thymocytes. Symmetrically, Tcf12 transcription (encoding HEB) was strongly
downregulated (Fig. 5b and Supplementary Fig.1). Another hallmark of positive selection
was the 4-fold upregulation of the recently described MHC class I transactivator, Nlrc5 69
(Fig. 5b). Although expression levels of MHC-I molecules were markedly impaired in
Nlrc5-deficient mice (Fig. 5c), the increase upon positive selection was largely parallel in
WT and Nlrc5-deficient mice, indicating that other factors modulate MHC class I expression
at this step. Many of the other transcriptional regulators have no reported function in thymic
differentiation and warrant future exploration (Fig. 5b).
Gene ontology and manual curation of the fraction of the CD69+ DP transcriptome that was
not part of the generic TCR activation signature identified several other enriched functional
categories (Supplementary Fig. 6 and Supplementary Table 3). In particular, the
“metabolic” category represented 11% of the induced genes, with genes involved in several
major biosynthetic and oxidative pathways. The tricarboxylic acid cycle emerged as a
critical metabolic hub in the transition from small DP to CD69+ DP, with concerted
transcriptional regulation of key regulators of the pyruvate dehydrogenase complex (PDH).
CD69+ DP thymocytes downregulated two of the most active PDK isozymes (Pdk1 and
Pdk2), kinases that catalyze the phosphorylation and inactivation of the PDH complex, and
simultaneously increased the expression of Pdp1 and Pdp2 phosphatases that catalyze the
opposite reaction (Fig. 5d). In addition to this coordinate regulation of Pdk and Pdp (which
is also observed in starving cells 70), CD69+ DP thymocytes reactivated the upstream
glycolytic pathway (Fig. 5d), with the upregulation of Pgam1 (the most abundant 3-
phosphoglycerate mutase in thymocytes) and the downregulation of Pgm2l1 (Glu-1,6-biP
synthase, whose reaction product negatively regulates hexokinase isozymes) 71.
This metabolic switch was also associated with the reactivation of other cellular
housekeeping activities, which altogether composed almost 30% of the upregulated
transcriptome that was not part of the early TCR activation signature. These included the
restoration of active protein synthesis (representing 10% of upregulated genes);
nucleocytoplasmic transport (2%); and cytoskeleton-based motility (6%) (Supplementary
Fig. 6 and Supplementary Table 3). One revealing example was the upregulation of 20
ribosome structural proteins and key regulators of translation, such as the ribosomal S6
kinase (Rps6ka1) (Fig. 5e). Importantly, for most of the genes in these categories, the
upregulation was only partial at the CD69+ DP stage (Fig. 5e), and only completed by the
mature SP stages. This step-wise reactivation was also reflected in cellular RNA content, as
well as transcriptional rates, which were only gradually increased during the differentiation
of DP thymocytes into mature SP cells (Fig. 4c-d). Therefore, rather than a simple shift in
the balance of pro- and anti-apoptotic factors, the CD69+ DP stage was characterized by the
reactivation of most cellular housekeeping functions downregulated at the small DP stage.
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generally accepted that expression of CD69 identifies DP thymocytes recently engaged in
positively-selecting TCR-pMHC interactions 3, 65, it is not clear which (if any) fraction of
TCR-triggered CD69+ DP thymocytes is doomed to die following TCR engagement with
negatively-selecting pMHC ligands 72-77. To address this question, we highlighted those
genes that have been reproducibly associated with negative selection in TCR transgenic
models (Nr4a1 (NUR77), Bcl2l11 (BIM), Pdcd1 (PD1), and Gadd45b 29, 30, 78) on a volcano
plot comparing the CD69+ DP and small DP stages (Fig. 6a). These genes were strongly
induced in CD69+ DP cells, suggesting that negative selection may indeed have a substantial
footprint on the transcriptome of CD69+ DP thymocytes.
To determine whether we could distinguish positive and negative selection at the
transcriptional level, we next compared the transcriptomes of CD69+ DP and CD4+CD8int
(intermediate CD4SP) thymocytes, which correspond to the earliest positively selected cell
population that ultimately gives rise to both CD4 and CD8 lineages 7 (Fig. 6b). As expected,
the vast majority of genes upregulated in CD69+ DP thymocytes showed similar expression
in CD4+CD8int cells (e.g., Cd53, Bcl2 and H2-k1), confirming that positive selection was a
major contributor to the CD69+ DP transcriptome. However, a subset of the upregulated
genes was more highly expressed in CD69+ DP than in intermediate CD4SP (e.g., Nr4a1,
Gadd45b, Pdcd1, and Bcl2l11), or vice-versa (e.g., Nlrc5, Il7r, and Gimap3/4). This
divergence of the transcriptional profiles suggested putative markers associated with
positive and negative selection.
We thus explored the expression of some of these markers by flow cytometry to determine
whether a subset of CD69+ DP cells was associated with apoptosis. The combined use of
antibodies directed against MHC class I (upregulation of which was one transcriptional
hallmark of positively selected cells observed in Fig. 6b, e.g. H2-k1) and CD69 subdivided
thymocytes into 5 clear subpopulations (see Supplementary Fig. 7 for gating strategy). Two
distinct phenotypes could be discerned in the CD69hiMHCIneg thymocyte fraction (Fig. 6c).
The CD4dullCD8dull subset contained a high proportion of cells with high levels of NR4A1,
PD-1, and HELIOS (encoded by Ikzf2) and little or no BCL2 and IL-7R (Fig. 6d). In
contrast, the CD4+CD8int subset showed exactly opposite expression patterns for these
markers (Fig. 6d). These results suggested that the CD4dullCD8dullCD69hiMHCIneg subset
was enriched in cells at an early stage of deletion by apoptosis.
To test this hypothesis, we analyzed the activation of Caspase-3 (Fig. 6e). Interestingly, the
CD4dullCD8dull population had a singularly high frequency of activated Caspase-3+ cells (up
to 3%), even when compared with immature SP populations, known to be sensitive to clonal
deletion (Fig. 6e and Supplementary Fig. 7). Note that activated Caspase-3+ cells in the
CD4dullCD8dull population included CD69neg and CD69hi cells, which were both markedly
decreased in MHC class I and II-deficient mice (by 10 and 100-fold) and in Bim-deficient
mice (by 4-fold) (Fig. 6e-f), thereby identifying a DP thymocyte subset in unmanipulated
mice undergoing cell death in a MHC- and Bim-dependent manner, which is characteristic
of bona-fide clonal deletion. Small DP cells also contained a significant proportion of
CD69neg activated Caspase-3+ cells, which, in contrast to the CD4dullCD8dull population,
was increased in the absence of MHC class I and II molecules (Fig. 6f), likely identifying
cells dying by neglect. Altogether, these observations revealed a surprisingly large deletional
program within the polyclonal repertoire of DP thymocytes.
Differentiation of CD4 and CD8 lineages
The above results indicated that the CD69+ DP subset was a heterogeneous population, with
only a fraction of the cells differentiating from the DP to SP stage. This differentiation event
comprised one of the largest changes observed during thymocyte differentiation, with
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tvariations in the expression of more than 2600 gene probes (Fig. 1e and Fig. 7a). Despite the
scale of this transcriptome shift, most of the changes were common for both CD4 and CD8
lineages (approximately 93%), with surprisingly few genes differentially expressed (Fig.
7a). Among these, Cd40l and Tnfrsf4 (OX40) were specifically upregulated in the CD4
lineage, while Crtam and Cd226 genes, associated with granule- and IFN-γ -mediated
cytotoxic functions 79, were more highly expressed in the CD8 lineage. Correspondingly,
very few transcriptional regulators were differentially expressed, exemplified by the well-
described Zbtb7b (THPOK) and Gata3 on the CD4 side, Runx3 and Eomes on the CD8
side 80 (Fig. 7b). Thus, the CD4 and CD8 lineages are distinguished by surprisingly few
transcriptional marks during thymocyte differentiation.
Thymic egress is coupled with a phase of functional maturation 23. To test the hypothesis
that this maturation phase could reinforce lineage identities and further demarcate their
transcriptomes, we compared thymic and peripheral T cells (Fig. 8a). Surprisingly, little
evidence of such a maturation process was observed at the transcriptional level. Most
downregulated genes were cell-cycle-related and probably reflected the small fraction of
proliferating mature SP thymocytes 81. Only 12 genes showed a significant upregulation in
peripheral T cells relative to mature thymic counterparts (with a FC threshold of 2) (Fig. 8a).
One of these genes was Cd55, whose gene product deactivates complement C3 convertases
and protects cells from the lytic action of complement, while the function of another, Dapl1,
is unknown in T cells. The upregulation of these genes upon thymic egress was similar in
CD4 and CD8 lineages (Fig. 8a). Finally, a small subset of genes selectively downregulated
in peripheral CD4+ T cells reflected the inclusion of Treg cells in the thymic, but not the
lymph node, CD4+ subset. These observations demonstrated that thymic egress had limited
transcriptional consequences, with no reinforcement of CD4 and CD8 lineage identities.
What ultimately defines lineage identities in peripheral T cells? In line with the thymocyte
profiling, a direct comparison of peripheral CD4+ and CD8+ T cells revealed few
differentially expressed gene probes (159 at a FC threshold of 2, FDR<10−4), most of which
overlapped with those previously detected in thymocytes (Fig. 8b). A few of these genes
were associated with TCR signaling functions: Cd28, Trib2 (a negative regulator of MAPK),
and Mapk11 (p38beta) on the CD4+ side; Dpp4 (CD26) and Rnf125 (a positive regulator of
T cell activation) on the CD8+ side. Such limited divergence is surprising, given the
physiologically distinct functions of CD4+ and CD8+ T cells. We reasoned that these modest
differences in the baseline transcriptomes might be amplified upon activation and/or
reflected in post-translational cascades during activation.
Therefore, we compared TCR signaling events in CD4+ and CD8+ T cells using
multidimensional mass cytometry (CyTOF) 34. Lymph node cell suspensions were
stimulated with anti-CD3 and -CD28 antibodies and interrogated for the phosphorylation
status of 15 intracellular signaling molecules and the expression of 7 cell surface markers,
across 15 time-points (Fig. 8c). Despite a slightly higher level of phosphorylation in CD4+ T
cells, most key TCR-proximal (CD3ζ , ZAP-70, LAT, SLP-76) and downstream nodes
(ERK1/2, S6, MAPKAPKII, NF-κ B) had very similar dynamics of phosphorylation in CD4+
and CD8+ T cells, mirroring the transcriptional similarity. We also isolated anti-CD3 and
anti-CD28-stimulated CD4+ and CD8+ peripheral T cells for gene expression profiling (Fig.
8d). Reminiscent of maturation-induced changes in thymocytes, the vast majority of
activation-induced changes in the transcriptomes of CD4+ and CD8+ cells were shared (Fig.
8d). Nonetheless, some divergence of CD4+ and CD8+ transcriptional programs was evident
as early as one hour following TCR stimulation and, surprisingly, included lineage-specific
downregulation of the master transcriptional regulators of each lineage (Zbtb7b, Gata3,
Runx3 and Eomes).
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tTranscriptional divergence of CD4+ and CD8+ T cells increased over time (Fig. 8d). One
example was Xcl1, whose product attracts dendritic cells and is crucial for an efficient
cytotoxic response 82. Other chemokine genes like Ccl3 (MIP1α ) and Ccl4 (MIP1β ), as well
as genes directly involved in CD8+ cell functions (Crtam and Gzmb), were also selectively
regulated (Fig. 8d). On the CD4+ cell side, preferentially expressed genes included Il2, Il2rb,
Tnfsf4 (OX40L), Tnfrsf4 (OX40), among others. Therefore, the great similarity between the
transcriptomes of CD4 and CD8 lineages, acquired upon positive selection, persisted
through peripheral migration and was reflected in their signaling and transcriptional
responses to TCR stimulation. This close transcriptional similarity contrasts with our
perception of their very different functions.
Discussion
Our analysis of the entire transcriptional spectrum of thymocyte differentiation states
revealed several new insights. Dual control of Myc expression at the transcriptional and
post-transcriptional levels (via the downregulation of Mxi1, Sin3b and Trpc4ap) was
apparent at the small DP to CD69+ DP transition, as at the β -selection checkpoint,
compatible with the notion that MYC constitutes the cellular rheostat that enforces the
programmed starving at the small DP stage and the reactivation of cellular functions upon
positive selection. Although the precise function of MYC at this stage remains to be
investigated, several lines of evidence argue in favor of this possibility. First, the inhibition
of MYC activity via the overexpression of MYC-inhibitor MAD1 led to a decreased cell
size of SP thymocytes, as well as a decrease in the proportion of CD3hi mature SP
thymocytes 59. Second, although no phenotype was reported in mice overexpressing or
deleting Myc at the DP stage in polyclonal settings 53, 83, Myc overexpression in DP
thymocytes of HY TCR transgenic mice led to a significant increase in positive selection
efficiency 83.
The expression of a complete αβ TCR renders DP thymocytes eligible for positive selection.
Whether significant levels of negative selection also occur at this stage in an unmanipulated,
polyclonal setting has been a controversial question. Our expression profiling uncovered a
program associated with apoptotic deletion within the early CD69+ DP subset, a
consequence of their first TCR-pMHC interactions. By tracking a variety of proteins
identified through this transition, we could ascribe this program to a subset of
CD69hiMHCIneg DP thymocytes with activated CCaspase-3, identifying a distinct fraction
of DP undergoing deletion. Future studies that take into account the dynamics of this process
will be required to more precisely quantify this early wave of cortical deletion relative to
negative selection in the thymic medulla.
This Resource also provides an important reference for T-cell diseases such leukemia,
immunodeficiency and autoimmunity. The transcriptomes of each thymocyte subset allows
for more precise staging of malignancies or identifying how differentiation stalls in the
context of transcriptional networks. For example, a recent study found that T-cell acute
lymphoblastic leukemia induced by Tcf-1-deficiency was, in fact, driven by dysregulation of
Lef-1 84, highlighting the interdependence of the transcription factors driving early
thymocyte differentiation. Furthermore, the definition of the normal dynamic of
transcriptional regulation throughout thymocyte differentiation will enable the identification
of the origins of network perturbations in disease-relevant models.
In conclusion, the comprehensive resolution of αβ  T cell transcriptomes through the entire
course of their differentiation yields a unique perspective that colors somewhat differently
our appreciation of differentiative events: the apparently gradual nature of commitment to
the T cell lineage, the deep shutdown of cortical DP thymocytes followed by cellular
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treactivation upon positive selection, the quasi-identity of CD4+ and CD8+ T cells. We were
able to take stock of the uncharted space across key transitions in thymocyte differentiation
and highlight many interesting candidate genes that are unexplored in T cells. Very few of
the transcriptional regulators identified through the DP transitions have been analyzed, while
almost all of the [rare] transcription factors differentially expressed between CD4+ and
CD8+ T cells have already been characterized. Thus, this analysis sets the boundaries of the
“known unknown” in αβ T cell differentiation and the challenge now is to integrate these
with the “knowns” for a more complete view of T cell biology.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Bird’s-eye view of transcriptome changes in the course of T cell differentiation. (a)
Maximum-normalized mean expression values for Rag1, Tcra and Kit in indicated BM and
thymocyte populations. (b) Hierarchical clustering, (c) Principal Component Analysis and
(d) heatmap of Euclidian distances between indicated populations, calculated using the 15%
of probes with the greatest difference in expression among these subsets and with expression
values over 120 for at least one of the subsets. Expression values were log2-transformed and
row-standardized prior to the analysis. (e) Number of probes upregulated (red symbols) or
downregulated (blue symbols) by 2-fold or more at the indicated transitions during T cell
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tdifferentiation. Filled symbols, total number of probes; open symbols, number of probes
which are not part of the proliferation signature.
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Dynamics of gene expression during early T cell differentiation. K-means clusters of genes
showing differential expression during early T cell differentiation. (a) Log2-transformed
mean-centered expression values for the genes (black lines) and cluster centroids (grey line)
for each cluster. Clusters are named by a characteristic gene or group of genes in the cluster.
The complete list of genes in each cluster is provided in Supplementary Table 2. (b)
Heatmaps showing expression levels of genes from PU.1 (left), TCF-1/LEF-1 (top right),
and CD4/CD8 (bottom right) clusters. (c) Heatmaps showing expression levels of
transcriptional regulators from indicated clusters. (d) Heatmap showing expression levels of
diacylglycerol kinase genes whose expression changed by 3-fold or more during early T cell
differentiation.
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Transcriptional footprint of β -selection. (a) Volcano plot comparing DN3b and DN3a
thymocyte stages (Fold Change: x axis; t test p-value: y axis). Probes corresponding to the
proliferation signature (see Methods section for definition) and components of NOTCH
signaling pathway are highlighted in blue and red, respectively. (b) Fold change/FC plots
comparing transcriptome changes induced by preTCR signaling in DN thymocytes (DN3b
vs DN3a, x-axis) versus αβ TCR signaling in DP thymocytes (top, CD69+ DP (DP69+)
versus small DP (DPsm), y-axis) and in peripheral T cells (bottom, OT1 TCR transgenic
cells, 24 hours after Listeria-OVA infection vs naïve OT1 cells). Blue lines mark a FC of 2.
(c) Maximum-normalized mean expression of Notch1 and indicated NOTCH target genes in
thymocyte subsets. (d) Histogram showing expression levels of MYC, detected by flow
cytometry (left) and maximum-normalized mRNA levels of Myc and negative regulators of
MYC in the indicated thymocyte populations (right). MYC protein levels are indicated with
a dashed line for comparison. Flow cytometry analysis of MYC expression is representative
of 3 independent experiments. (e) Schematic of the proposed model describing the interplay
between the preTCR, NOTCH1, IL-7R and MYC in T cell physiology during early T cell
differentiation.
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Transcriptional shutdown in small DP thymocytes. (a) Heatmaps showing normalized
expression values for probes belonging to the GO categories for: ribosome and translation
(GO:0005840 and 0006412) (top); mitochondrion (GO:0005739) (middle); and cell cycle
(GO:0007049) (bottom) across BM progenitor, B cell, myeloid and T cell subsets. Probes
are sorted by increasing value in small DP (DPsm). (b) Scatter plot showing ‘proliferation’
and ‘translation’ indexes calculated by averaging row maximum-normalized expression
values for each probe in the proliferation signature (‘proliferation’ index) or translation and
ribosome categories (‘translation’ index), for the same set of cell populations shown in (a).
(c) Pyronin Y quantification of total RNA content in thymocytes. Histogram overlay (top)
and mean fluorescence intensity (bottom) in indicated thymocyte subsets. (d) Analysis of
transcriptional activity via eU incorporation. Total thymocytes were incubated for 2 hrs in
presence of eU nucleotide, followed by flow cytometric detection of incorporated eU by
click chemistry. Representative eU saining histograms (left) and corresponding mean
fluorescence intensity (right) in indicated thymocyte subsets. Panels (c) and (d) are
representative of two independent experiments.
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Reactivation of housekeeping activities upon positive selection. (a) Volcano plot comparing
CD69+ DP (DP69+) and small DP (DPsm) thymocytes (Fold Change: x axis; t test p-value:
y axis). Signature genes upregulated (violet) and downregulated (cyan) at early time points
following in vitro TCR stimulation of DP thymocytes are highlighted. Signature genes were
derived from the previously described transcriptome analysis of BDC2.5 TCR transgenic DP
thymocytes 30, and include all genes induced or repressed (FC threshold of 2) at 3 h or 7 h
post-stimulation with mimotope-pulsed splenic APCs. The number of signature genes in the
upregulated and downregulated transcriptome, are indicated. Immediate early response
genes (orange) were derived from the transcriptome analysis of a PDGF-stimulated cell
line 85. (b) Gene probes remaining after subtraction of TCR-stimulated DP signature genes
(highlighted in (a)). Transcriptional regulators upregulated (violet) and downregulated
(cyan) are highlighted (using a list of 1,680 known or putative transcriptional regulators,
provided in Supplementary Table 4). (c) Relative expression of MHC class I on indicated
thymocyte subsets, detected by flow cytometry with anti-H2-Kb (green) and H2-Db (blue)
antibodies in Nlrc5-sufficient (solid lines), and Nlrc5-deficient mice (dashed lines). (d)
Maximum-normalized mean expression of 8 metabolism-related transcripts regulated at the
small DP to CD69+ DP transition, whose gene-products control key steps of the glycolytic
and tricarboxylic acid cycle pathways. The schematic diagram displays the function of each
of the corresponding enzymes along the glycolytic and tricarboxylic acid cycle pathways.
Abbreviations: Glu=glucose; P=phosphate; G=glycerate; Pyr=pyruvate; PDH=pyruvate
dehydrogenase; HK=hexokinase (e) Maximum-normalized expression of 20 ribosome and
translation-related transcripts regulated at the small DP to CD69+ DP transition. The
following genes encode the structural ribosomal proteins: Rpl3, Rpl37, Rpl38, Rpl39,
Rplp1, Rps12, Rps20, Rps25, Rps28, Rps29, Rrp15, Rpsa.
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Transcriptional and functional footprints of clonal deletion in CD69+ DP thymocytes. (a)
Volcano plot comparing CD69+ DP (DP69+) and small DP (DPsm) thymocytes (Fold
Change: x axis; t test p-value: y axis). Genes which have been reproducibly associated with
negative selection in TCR transgenic models are highlighted in red. (b) Fold change/FC plot
showing transcriptome changes induced in CD69+ DP (DP69+) (x-axis) and intermediate
(CD4+CD8int) thymocytes, relative to small DP (DPsm). Blue lines mark a FC >2. Genes
induced by >2-fold in CD69+ DP thymocytes and showing higher (violet), similar (gray), or,
lower (red) upregulation in intermediate thymocytes are highlighted. (c) Expression of CD4
and CD8 on CD69negMHCIneg (top) or CD69hiMHCIneg (bottom) thymocytes (see gating
strategy in Supplementary Fig. 7). The frequencies of cells falling within each gate are
indicated. (d) Cell surface expression of PD-1, IL-7R, CD5, TCRβ , and intracellular
expression of IKZF2 (HELIOS), NR4A1, BCL2 on indicated subpopulations (see key).
Panels (c-d) are representative of three independent experiments. (e) Intracellular expression
of the activated, cleaved form of Caspase-3 (Act-Casp.3) and CD69 on subpopulations
defined in panels (c-d), from WT and b2m−/−.Iab−/− (Mhc−/−) mice. (f) Proportion of
activated Caspase-3+ cells within the indicated thymocyte subpopulations from
b2m−/−.Iab−/− (Mhc−/−), Bcl2l11−/− mice (Bim−/−) and wild-type (WT) mice. Each pair of
mice corresponds to one experiment.
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Acquisition of CD4 and CD8 transcriptional identities during thymocyte differentiation. (a)
Fold change/FC plot showing transcriptome changes induced in mature CD4SP (4SP24−) (x-
axis) and mature CD8SP (8SP24−) thymocytes (y-axis), relative to small DP (DPsm). Blue
lines mark a FC of 2. Genes showing similar (gray) or preferential upregulation during
CD4SP (red) or CD8SP (blue) differentiation are highlighted (FC threshold of 2, with the
corresponding number of genes indicated). (b) Same as (a), filtered using a list of 1,680
known or putative transcriptional regulators (provided in Supplementary Table 4).
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Definition of CD4 and CD8 transcriptional identities. (a) Fold change/FC plot showing
transcriptome changes induced in lymph node CD4 (x-axis) and CD8 T cells (y-axis),
relative to their respective thymic parental populations, mature CD4SP (4SP24−) (x-axis)
and mature CD8SP (8SP24−) thymocytes (y-axis). Blue lines mark a FC of 2. Genes
upregulated by >2-fold in peripheral CD4 and CD8 T cells, relative to their thymic
counterparts, are highlighted in orange. Treg cell-related and proliferation signature genes
are highlighted in green and blue, respectively (see text). (b) Expression/expression plot
comparing lymph node CD4 (x-axis) and CD8 T cell transcriptomes (y-axis). Genes
preferentially expressed in CD4+ (red) or CD8+ (blue) T cells are highlighted, with the
corresponding number of gene probes. Transcriptional regulators are indicated in bold. (c)
Heatmaps showing the level of phosphorylation of indicated signaling molecules in CD8+
(left) and CD4+ (right) lymph node T cells, detected simultaneously by mass cytometry at
multiple time points following anti-CD3 and anti-CD28 crosslinking. Cells were fixed after
antibody crosslinking at the indicated time points and analyzed on the CyTOF instrument.
First column, unstimulated cells; Last column, PMA positive control. Panel c is
representative of 4 independent experiments. (d) Fold change/FC plots showing
transcriptome changes induced in anti-CD3and anti-CD28 stimulated CD4+ (x-axis) and
CD8+ lymph node T cells (y-axis), relative to corresponding unstimulated cell populations at
the indicated time points. Blue lines mark a FC of 2. Genes showing similar (gray) or
lineage preferential regulation in CD4+ T cells (red) or CD8+ T cells (blue) are highlighted
(FC threshold >2, with the corresponding number of genes indicated).
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